Gastroesophageal Junction Cancer
Symptoms, Doctors, Treatments, Advances & More

Gastroesophageal Junction Cancer Overview

Save information for later
Sign Up

Learn About Gastroesophageal Junction Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Gastroesophageal Junction Cancer Local Doctors?
Elite in Gastroesophageal Junction Cancer
Hematology | Oncology
Elite in Gastroesophageal Junction Cancer
Hematology | Oncology
Referral may be required

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Experience:
26+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

I decided to go to medical school during the early part of college and then never really looked back. I enjoyed every discipline while I was in medical school and had a difficult time selecting a specialty, until I did a rotation in Hematology/Oncology. After observing the relationships that oncologists develop with patients and their families, I knew that medical oncology was the right place for me. Getting to know my patients and their families and helping them achieve their goals, despite a cancer diagnosis, has become extremely important to me. I also enjoy working as part of a multidisciplinary team to make sure that patients get the most comprehensive care possible. When I am not working, I enjoy spending time with family, reading, and running. Dr. Uronis is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Gastroesophageal Junction Cancer, Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Pancreaticoduodenectomy. Dr. Uronis is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Uronis is currently accepting new patients.

Elite in Gastroesophageal Junction Cancer
Elite in Gastroesophageal Junction Cancer
Referral may be required
Leuven, VLG, BE 

Eric Van Cutsem practices practicing medicine in Leuven, Belgium. Mr. Van Cutsem is rated as an Elite expert by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Gastroesophageal Junction Cancer, Colorectal Cancer, Stomach Cancer, Liver Embolization, and Gastrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Gastroesophageal Junction Cancer
Hematology | Oncology
Elite in Gastroesophageal Junction Cancer
Hematology | Oncology
Referral may be required

Brown University Health Cancer Institute

110 Lockwood St, 
Providence, RI 
Languages Spoken:
English
Offers Telehealth

Howard Safran is a Hematologist and an Oncologist practicing medicine in Providence, Rhode Island. Dr. Safran is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Gastroesophageal Junction Cancer, Gallbladder Adenocarcinoma, Squamous Cell Carcinoma of the Anal Canal (SCAC), Ampullary Cancer, and Pancreaticoduodenectomy.

What are the latest Gastroesophageal Junction Cancer Clinical Trials?
Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination With Azenosertib (ZN-c3) in HER2-Expressing/Amplified Gastric/Gastroesophageal Junction Cancer and Other Solid Tumors

Summary: This phase I trial tests the safety, side effects, and best dose of azenosertib in combination with trastuzumab deruxtecan in treating patients with HER2-positive gastric or gastroesophageal junction cancer and other HER2-positive solid tumors that have spread to nearby tissue or lymph nodes (locally advanced), that have spread from where it first started (primary site) to other places in the body...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Single-arm Study Evaluating the Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer

Summary: Siewert type II/III gastroesophageal junction (GEJ) adenocarcinoma is a challenging malignancy located at the anatomical transition between the esophagus and stomach. Due to its complex anatomical location and mixed biological characteristics of esophageal and gastric cancers, the optimal surgical strategy remains controversial. Current surgical approaches vary in terms of operative access, extent...